Benny Esquenazi
Obstetrics & Gynecology · Pembroke Pines, FLNPI 1417970377
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,581 of the $1,769 with a category attached, or 89.3%. It is spread thinly across 27 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $528 and has fallen 75.9% since, to $128 in 2025.
Across 78 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$361
- AbbVie$301
- Scynexis, Inc.$140
- Mylan Pharmaceuticals Inc.$102
- Aroa Biosurgery Incorporated$98
- Therapeuticsmd, Inc.$79
- plus $688 from 21 others
Across 108 payments — averaging $631.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$68K
What the payments were for
- Food & beverage$1,58189%
- Education$18911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $361 |
| AbbVie(2 entities) | 15 | $301 |
| Scynexis, Inc. | 5 | $140 |
| Mylan Pharmaceuticals Inc. | 5 | $102 |
| Aroa Biosurgery Incorporated | 2 | $98 |
| Therapeuticsmd, Inc. | 5 | $79 |
| Pfizer | 3 | $68 |
| Mayne Pharma Commercial LLC | 3 | $63 |
| Avion Pharmaceuticals | 4 | $57 |
| Agile Therapeutics, Inc. | 3 | $49 |
| AMAG Pharmaceuticals, Inc. | 2 | $49 |
| Bayer | 2 | $47 |
| Millicent US Inc | 2 | $47 |
| Mission Pharmacal Company | 2 | $45 |
| Lupin Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| Smith+Nephew | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Coloplast | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Exeltis, USA Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Myovant Sciences Inc. | 1 | $14 |
| Dysis Medical, Inc. | 1 | $13 |
| Coopersurgical, Inc. | 1 | $13 |
How this compares
$1,769 in reported general payments places this provider in the 65th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Pembroke Pines
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.